96 related articles for article (PubMed ID: 31128428)
21. Does access to private healthcare influence potential lung cancer cure rates?
John TJ; Plekker D; Irusen EM; Koegelenberg CFN
S Afr Med J; 2017 Jul; 107(8):687-690. PubMed ID: 28809615
[TBL] [Abstract][Full Text] [Related]
22. The accuracy of Japanese claims data in identifying breast cancer cases.
Sato I; Yagata H; Ohashi Y
Biol Pharm Bull; 2015; 38(1):53-7. PubMed ID: 25744458
[TBL] [Abstract][Full Text] [Related]
23. Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis.
Halpern MT; Ward EM; Pavluck AL; Schrag NM; Bian J; Chen AY
Lancet Oncol; 2008 Mar; 9(3):222-31. PubMed ID: 18282806
[TBL] [Abstract][Full Text] [Related]
24. [Value of computed tomography in the staging and predicting resectability of primary advanced ovarian carcinoma].
Lou FL; Shi YF
Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):701-5. PubMed ID: 17274380
[TBL] [Abstract][Full Text] [Related]
25. Distance from accessible specialist care and other determinants of advanced or unknown stage at diagnosis of people with non-small cell lung cancer: A data linkage study.
Tracey E; McCaughan B; Badgery-Parker T; Young J; Armstrong B
Lung Cancer; 2015 Oct; 90(1):15-21. PubMed ID: 26275475
[TBL] [Abstract][Full Text] [Related]
26. Prognostic Value of a Long Non-coding RNA Signature in Localized Clear Cell Renal Cell Carcinoma.
Qu L; Wang ZL; Chen Q; Li YM; He HW; Hsieh JJ; Xue S; Wu ZJ; Liu B; Tang H; Xu XF; Xu F; Wang J; Bao Y; Wang AB; Wang D; Yi XM; Zhou ZK; Shi CJ; Zhong K; Sheng ZC; Zhou YL; Jiang J; Chu XY; He J; Ge JP; Zhang ZY; Zhou WQ; Chen C; Yang JH; Sun YH; Wang LH
Eur Urol; 2018 Dec; 74(6):756-763. PubMed ID: 30143382
[TBL] [Abstract][Full Text] [Related]
27. Five microRNAs in plasma as novel biomarkers for screening of early-stage non-small cell lung cancer.
Geng Q; Fan T; Zhang B; Wang W; Xu Y; Hu H
Respir Res; 2014 Nov; 15(1):149. PubMed ID: 25421010
[TBL] [Abstract][Full Text] [Related]
28. Serum biomarkers facilitate the recognition of early- stage cancer and may guide the selection of surgical candidates: a study of carcinoembryonic antigen and tissue polypeptide antigen in patients with operable non-small cell lung cancer.
Buccheri G; Ferrigno D
J Thorac Cardiovasc Surg; 2001 Nov; 122(5):891-9. PubMed ID: 11689793
[TBL] [Abstract][Full Text] [Related]
29. Real-world treatment patterns and costs in a US Medicare population with metastatic squamous non-small cell lung cancer.
Davis KL; Goyal RK; Able SL; Brown J; Li L; Kaye JA
Lung Cancer; 2015 Feb; 87(2):176-85. PubMed ID: 25532680
[TBL] [Abstract][Full Text] [Related]
30. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
31. Disparities in stage at diagnosis among adults with testicular germ cell tumors in the National Cancer Data Base.
Lerro CC; Robbins AS; Fedewa SA; Ward EM
Urol Oncol; 2014 Jan; 32(1):23.e15-21. PubMed ID: 23395701
[TBL] [Abstract][Full Text] [Related]
32. Factors associated with delivery of neoadjuvant chemotherapy in women with advanced stage ovarian cancer.
Hinchcliff E; Melamed A; Bregar A; Diver E; Clemmer J; Del Carmen M; Schorge JO; Alejandro Rauh-Hain J
Gynecol Oncol; 2018 Jan; 148(1):168-173. PubMed ID: 29128105
[TBL] [Abstract][Full Text] [Related]
33. Development and Validation of an Algorithm to Identify Endometrial Adenocarcinoma in US Administrative Claims Data.
Esposito DB; Banerjee G; Yin R; Russo L; Goldstein S; Patsner B; Lanes S
J Cancer Epidemiol; 2019; 2019():1938952. PubMed ID: 31781220
[TBL] [Abstract][Full Text] [Related]
34. Prediction of Early Death in Patients with Early-Stage NSCLC-Can We Select Patients without a Potential Benefit of SBRT as a Curative Treatment Approach?
Klement RJ; Belderbos J; Grills I; Werner-Wasik M; Hope A; Giuliani M; Ye H; Sonke JJ; Peulen H; Guckenberger M
J Thorac Oncol; 2016 Jul; 11(7):1132-9. PubMed ID: 27060654
[TBL] [Abstract][Full Text] [Related]
35. Predicting Occurrence of Spine Surgery Complications Using "Big Data" Modeling of an Administrative Claims Database.
Ratliff JK; Balise R; Veeravagu A; Cole TS; Cheng I; Olshen RA; Tian L
J Bone Joint Surg Am; 2016 May; 98(10):824-34. PubMed ID: 27194492
[TBL] [Abstract][Full Text] [Related]
36. Health insurance and stage at diagnosis of laryngeal cancer: does insurance type predict stage at diagnosis?
Chen AY; Schrag NM; Halpern M; Stewart A; Ward EM
Arch Otolaryngol Head Neck Surg; 2007 Aug; 133(8):784-90. PubMed ID: 17709617
[TBL] [Abstract][Full Text] [Related]
37. Merkel cell carcinoma: incidence, mortality, and risk of other cancers.
Kaae J; Hansen AV; Biggar RJ; Boyd HA; Moore PS; Wohlfahrt J; Melbye M
J Natl Cancer Inst; 2010 Jun; 102(11):793-801. PubMed ID: 20424236
[TBL] [Abstract][Full Text] [Related]
38. The Neiman Imaging Comorbidity Index: Development and Validation in a National Commercial Claims Database.
Pelzl CE; Rosenkrantz AB; Rula EY; Christensen EW
J Am Coll Radiol; 2024 Jun; 21(6):869-877. PubMed ID: 38276924
[TBL] [Abstract][Full Text] [Related]
39. Impact of race, socioeconomic status, and the health care system on the treatment of advanced-stage ovarian cancer in California.
Long B; Chang J; Ziogas A; Tewari KS; Anton-Culver H; Bristow RE
Am J Obstet Gynecol; 2015 Apr; 212(4):468.e1-9. PubMed ID: 25448522
[TBL] [Abstract][Full Text] [Related]
40. A Novel Nomogram and Risk Classification System Predicting the Cancer-Specific Survival of Patients with Initially Diagnosed Metastatic Esophageal Cancer: A SEER-Based Study.
Tang X; Zhou X; Li Y; Tian X; Wang Y; Huang M; Ren L; Zhou L; Ding Z; Zhu J; Xu Y; Peng F; Wang J; Lu Y; Gong Y
Ann Surg Oncol; 2019 Feb; 26(2):321-328. PubMed ID: 30357578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]